BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 11209973)

  • 1. Association of CagA-positive infection with Helicobacter pylori antibodies of IgA class.
    Rautelin HI; Oksanen AM; Karttunen RA; Seppälä KM; Virtamo JR; Aromaa AJ; Kosunen TU
    Ann Med; 2000 Dec; 32(9):652-6. PubMed ID: 11209973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Helicobacter pylori CagA antigen antibodies].
    Havlasová J; Bures J; Rejchrt S; Voxová B; Krejsek J
    Cas Lek Cesk; 1998 Jun; 137(13):404-9. PubMed ID: 9748734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection.
    Parsonnet J; Friedman GD; Orentreich N; Vogelman H
    Gut; 1997 Mar; 40(3):297-301. PubMed ID: 9135515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CagA antibodies in Japanese children with nodular gastritis or peptic ulcer disease.
    Kato S; Sugiyama T; Kudo M; Ohnuma K; Ozawa K; Iinuma K; Asaka M; Blaser MJ
    J Clin Microbiol; 2000 Jan; 38(1):68-70. PubMed ID: 10618065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum CagA antibodies in asymptomatic subjects and patients with peptic ulcer: lack of correlation of IgG antibody in patients with peptic ulcer or asymptomatic Helicobacter pylori gastritis.
    Graham DY; Genta RM; Graham DP; Crabtree JE
    J Clin Pathol; 1996 Oct; 49(10):829-32. PubMed ID: 8943750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CagA antibodies as a marker of virulence in chilean patients with Helicobacter pylori infection.
    Harris PR; Godoy A; Arenillas S; Riera F; García D; Einisman H; Peña A; Rollán A; Duarte I; Guiraldes E; Perez-Perez G
    J Pediatr Gastroenterol Nutr; 2003 Nov; 37(5):596-602. PubMed ID: 14581804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiplex serology of Helicobacter pylori antigens in detection of current infection and atrophic gastritis - A simple and cost-efficient method.
    Shafaie E; Saberi S; Esmaeili M; Karimi Z; Najafi S; Tashakoripoor M; Abdirad A; Hosseini ME; Mohagheghi MA; Khalaj V; Mohammadi M
    Microb Pathog; 2018 Jun; 119():137-144. PubMed ID: 29665437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histology and culture results among subjects with antibodies to CagA but no evidence of Helicobacter pylori infection with IgG ELISA.
    Ye W; Held M; Enroth H; Kraaz W; Engstrand L; Nyrén O
    Scand J Gastroenterol; 2005 Mar; 40(3):312-8. PubMed ID: 15932172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A CagA-independent cluster of antigens related to the risk of noncardia gastric cancer: associations between Helicobacter pylori antibodies and gastric adenocarcinoma explored by multiplex serology.
    Song H; Michel A; Nyrén O; Ekström AM; Pawlita M; Ye W
    Int J Cancer; 2014 Jun; 134(12):2942-50. PubMed ID: 24259284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Helicobacter pylori genotypes and their association with host's immune response].
    Garza-González E; Pérez-Pérez GI; Tijerina-Menchaca R; Maldonado-Garza HJ; Bosques-Padilla FJ
    Rev Gastroenterol Mex; 2002; 67(3):155-60. PubMed ID: 12653051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Helicobacter pylori cagA Gene with Gastric Cancer and Peptic Ulcer in Saudi Patients.
    Saber T; Ghonaim MM; Yousef AR; Khalifa A; Al Qurashi H; Shaqhan M; Samaha M
    J Microbiol Biotechnol; 2015 Jul; 25(7):1146-53. PubMed ID: 25791852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Helicobacter pylori IgA antibodies with the risk of peptic ulcer disease and gastric cancer.
    Kosunen TU; Seppala K; Sarna S; Aromaa A; Knekt P; Virtamo J; Salomaa-Rasanen A; Rautelin H
    World J Gastroenterol; 2005 Nov; 11(43):6871-4. PubMed ID: 16425400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-CagA and anti-VacA antibodies in Helicobacter pylori-infected patients with and without peptic ulcer disease in Serbia and Montenegro.
    Sokic-Milutinovic A; Wex T; Todorovic V; Milosavljevic T; Malfertheiner P
    Scand J Gastroenterol; 2004 Mar; 39(3):222-6. PubMed ID: 15074390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of high-sensitivity C-reactive protein (hs-CRP)in Helicobacter pylori-infected peptic ulcer patients and its association with bacterial CagA virulence factor.
    Jafarzadeh A; Hassanshahi GH; Nemati M
    Dig Dis Sci; 2009 Dec; 54(12):2612-6. PubMed ID: 19160050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local and systemic immune and inflammatory responses to Helicobacter pylori strains.
    Bhat N; Gaensbauer J; Peek RM; Bloch K; Tham KT; Blaser MJ; Perez-Perez G
    Clin Diagn Lab Immunol; 2005 Dec; 12(12):1393-400. PubMed ID: 16339062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence of eight Helicobacter pylori antigens among 182 patients with peptic ulcer, MALT gastric lymphoma or non-ulcer dyspepsia. Higher rate of seroreactivity against CagA and 35-kDa antigens in patients with peptic ulcer originating from Europe and Africa.
    Lamarque D; Gilbert T; Roudot-Thoraval F; Deforges L; Chaumette MT; Delchier JC
    Eur J Gastroenterol Hepatol; 1999 Jul; 11(7):721-6. PubMed ID: 10445790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helicobacter pylori and atrophic gastritis: importance of the cagA status.
    Kuipers EJ; Pérez-Pérez GI; Meuwissen SG; Blaser MJ
    J Natl Cancer Inst; 1995 Dec; 87(23):1777-80. PubMed ID: 7473834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of anti-Helicobacter pylori cagA IgG antibodies with resistance to first line treatment, bleeding gastroduodenal ulcers and gastric cancer.
    Ilie M; Dascălu L; Chifiriuc C; Popa M; Constantinescu G; Tănăsescu C; Baltac A
    Roum Arch Microbiol Immunol; 2011; 70(3):101-4. PubMed ID: 22570922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response of IgG1 and IgG2 subclasses to Helicobacter pylori in subjects with chronic inflammation of the gastric mucosa, atrophy and gastric cancer in a country with high Helicobacter pylori infection prevalence.
    Vorobjova T; Ren Z; Dunkley M; Clancy R; Maaroos HI; Labotkin R; Kull K; Uibo R
    APMIS; 2006 May; 114(5):372-80. PubMed ID: 16725014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum antibody positivity for distinct Helicobacter pylori antigens in benign and malignant gastroduodenal disease.
    Schumann C; Triantafilou K; Rasche FM; Möricke A; Vogt K; Triantafilou M; Hahn P; Schneider EM; Lepper PM
    Int J Med Microbiol; 2006 Aug; 296(4-5):223-8. PubMed ID: 16600680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.